101 – 110 of 619
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Single-cell transcriptional profiling informs efficient reprogramming of human somatic cells to cross-presenting dendritic cells
- Contribution to journal › Article
-
Mark
Rebuilding limbs, one cell at a time
- Contribution to journal › Article
-
Mark
Blood in a Lab: Using Immortalized Erythroid Cell Lines as a Source for Blood Transfusion
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Concurrent stem- and lineage-affiliated chromatin programs precede hematopoietic lineage restriction
- Contribution to journal › Article
-
Mark
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
- Contribution to journal › Article
-
Mark
Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations
- Contribution to journal › Letter
-
Mark
Cell-type profiling in salamanders identifies innovations in vertebrate forebrain evolution
- Contribution to journal › Article
-
Mark
Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
(2022) European Association for Cancer Research 2022 - Congress
- Contribution to conference › Poster
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
(2022) Lund Stem Cell Center Retreat
- Contribution to conference › Poster
